Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
03/2010
03/17/2010CN101669991A Gendarussa wine and manufacturing method and application thereof
03/17/2010CN101669973A Biological immunopotentiator composition for treating cancers
03/17/2010CN101669972A Preparation method of capsules for treating breast cancer
03/17/2010CN101669971A Compound extracted from shark cartilage marrows
03/17/2010CN101669970A Method for microwave extracting fat-soluble toad venom by using skin of Bufo bufo gargarizans
03/17/2010CN101669969A Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
03/17/2010CN101669968A Particle blood platelet dry powder preparation and preparation method thereof and application thereof
03/17/2010CN100594033C Chinese traditional medicine compound took orally for treating cervical spondylotic radiculopathy
03/17/2010CN100594032C Oral and external remedy for curing psoriasis
03/16/2010US7678930 Process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
03/16/2010US7678888 preparing a powdered form of a protein by mixing a solution of the protein with inulin and tagatose, and drying the mixture; stable at room temperature; Blood substitutes
03/16/2010US7678836 Method for rendering a contact lens wettable
03/16/2010US7678780 Method of treating cancer using platelet releasate
03/16/2010US7678777 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times
03/16/2010US7678758 For enhancing T cell response to tumour cells
03/16/2010US7678583 Method of lysis of erythrocytes
03/16/2010US7678573 Using plug flow bioreactor system which mimics bone marrow microenvironment for propagation and maintenance of stromal cells
03/16/2010US7678571 Procedure for the large-scale T-lymphocytes culture in a homogeneous system
03/16/2010US7678553 Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
03/16/2010US7678370 Methods of preventing peritonitis by administering lactic acid bacterium
03/16/2010CA2459981C For producing biologically active products
03/16/2010CA2397495C Composition for detecting beta-1,3-glucan, preparation method thereof and diagnostic kit detecting beta-1,3-glucan
03/16/2010CA2302838C Modulation of the sphingosine kinase signalling pathway
03/16/2010CA2287129C Stabilization of biological fluids by addition of sterol esters
03/16/2010CA2191577C Method for treating and preventing atherosclerosis
03/12/2010CA2639562A1 Use of cysteine-rich whey derived protein in patients receiving chemotherapy or radiotherapy to improve patient survival
03/11/2010WO2010027344A1 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
03/11/2010WO2010027280A1 Nitrobenzindoles and their use in cancer therapy
03/11/2010WO2010027094A1 NKT CELL-DERIVED iPS CELLS AND NKT CELLS DERIVED THEREFROM
03/11/2010WO2010027014A1 Method for improving absorption of s-adenosyl-l-methionine, and composition having improved s-adenosyl-l-methionine absorption
03/11/2010WO2010026575A2 Adherent cells from placenta tissue and use thereof in therapy
03/11/2010WO2010026574A2 Adherent cells from placenta tissue and use thereof in therapy
03/11/2010WO2010026299A1 Methods and means for soft tissue engineering
03/11/2010WO2010025548A1 Sperm fertility biomarkers and uses thereof
03/11/2010WO2010025506A1 Expansion of haemopoietic precursors
03/11/2010WO2010008879A3 Probiotic chewing gum method of manufacture
03/11/2010WO2009151301A3 Graft material for wound treatment and treatment method using vascular precursor cells derived from human embryonic stem cells
03/11/2010WO2009138582A3 Use of a composition containing 7-dehydrocholesterol or a natural extract of a vegetable or animal microorganism
03/11/2010WO2009107122A3 Methods, systems, compositions and dosage forms for diagnosing and treating male infertility
03/11/2010US20100063260 Whitefly Ecdysone Receptor Antibody
03/11/2010US20100063137 Cytotoxin Compound And Method of Isolation
03/11/2010US20100062040 Water soluble drugs and supplements
03/11/2010US20100062038 Markers, Antibodies and Recombinant scFvs for Mesenchymal Stem Cell Sub-populations and Osteoclasts
03/11/2010US20100062020 Method of Treating a Malignancy in a Subject Via Direct Picornaviral-Mediated Oncolysis
03/11/2010US20100062016 Microorganisms for therapy
03/11/2010US20100062013 Cancer antigen peptides derived from wt1
03/11/2010US20100062009 for cancer, immune, infectious and ischemic diseases; inhibiting tumor growth; allergy
03/11/2010US20100062007 Multi-modal cancer therapy using viral hitch-hiking
03/11/2010US20100061999 Antihuman tnf-alpha antibody activity lowering inhibitor
03/11/2010US20100061984 Compositions and methods for modulation of suppressor t cell activation
03/11/2010US20100061968 Reducing Cholesterol Levels with Combined Use of Quercetin and Statin
03/11/2010US20100061967 Use
03/11/2010US20100061966 Cardiac Stem Cells
03/11/2010US20100061964 Method for preparing pancreatic beta cells starting from beta cell progenitors and beta cells thereby obtained
03/11/2010US20100061937 Delivery of contrasting agents for magnetic resonance imaging
03/11/2010DE102008045815A1 Combination of an antibody and a bacterium, which expresses Fc-receptors or proteins, which bind the light chain of an antibody, useful for the treatment of tumors and their precursors, preferably colorectal carcinoma
03/11/2010CA2735800A1 Expansion of haemopoietic precursors
03/11/2010CA2735790A1 Adherent cells from placenta tissue and use thereof in therapy
03/11/2010CA2733249A1 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
03/10/2010EP2161329A1 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
03/10/2010EP1651628B1 Antibiotic compound
03/10/2010EP1641474B1 Therapeutical composition containing dentritic cells and use thereof
03/10/2010EP1483588B1 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders
03/10/2010EP1274833B1 A method to prevent graft rejection using tgf-beta to induce t suppressor cells
03/10/2010EP0830146B1 Methods of inducing immune tolerance using immunotoxins
03/10/2010CN101668534A IgA产生促进剂 IgA production promoting agent
03/10/2010CN101664420A Preparation process of Naoxuekang capsules
03/10/2010CN101664419A Traditional Chinese medicine for treating senile cataract
03/10/2010CN100593418C Spray for treating burn
03/09/2010US7674623 Method of stabilizing human natriuretic peptides
03/09/2010US7674613 Lactobacillus salivarius; gingivitis, periodontitis, periodontal disease, caries and halitosis
03/09/2010US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution
03/09/2010US7674468 Herpes simplex virus (HSV) comprising deletion, insertion, or substitution in each gamma 34.5 gene; lysis
03/09/2010US7674457 treating neurodegenerative disorders by administering a human umbilical cord blood and mannitol blood brain barrier permeabilizer; biodrug treating cerebral ischemia; cells are selected from all different organs
03/09/2010US7674456 Breast cancer cell lines and uses thereof
03/09/2010US7674455 treating a mammal having amyotrophic lateral sclerosis by transducing a motor neuron of the mammal with an insulin-like growth factor I (IGF-1) gene or a glial cell line-derived neurotrophic factor (GDNF) gene; neurodegenerative disorders
03/09/2010US7674291 Generating transgenic cell which express keratinocyte growth factor-2 (KGF-2) for use ase tool in treatment of ulcers and inflammatory bowel disease
03/09/2010CA2308904C Process for the inactivation of viruses
03/09/2010CA2159702C High molecular and low molecular fractions of von willebrand factor
03/04/2010WO2010024549A2 Bone filler containing a sustained-release therapeutic agent for osteoporosis
03/04/2010WO2010024413A1 Anticoccidium composition
03/04/2010WO2010023742A1 Method of producing cariostatic composition
03/04/2010WO2010023716A1 Microbial culture having anticancer effect and product using the microbial culture
03/04/2010WO2010023658A2 Compositions and methods for the treatment of glioblastoma
03/04/2010WO2010023366A1 Rough lps as an immunostimulant in aquatic farming
03/04/2010WO2010023291A1 Non-photosynthetic micro-organisms enriched with organic selenium from seleno-hydroxyacid compounds, and applications thereof in the fields of nutrition, cosmetics, and pharmaceuticals
03/04/2010WO2010023222A1 Administration unit comprising lactic acid bacteria
03/04/2010WO2010023178A1 Pharmaceuticals comprising a bacterial polysaccharide
03/04/2010WO2010022568A1 A medication for use in abstinence of drugs and preparation thereof
03/04/2010WO2010004334A3 Whitened exine shells
03/04/2010WO2009135199A3 Vaccine compositions and methods
03/04/2010WO2009114535A3 Bone paste composition
03/04/2010WO2009083768A3 Use of partly hydrolyzed fish gelatin for the preparation of topically administered pharmaceutical compositions
03/04/2010WO2009056703A8 Flavoured clay-based therapeutic composition
03/04/2010WO2009022338A3 Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
03/04/2010US20100056423 Bacterial-Derived BLIS for Treatment of Acne
03/04/2010US20100055763 Method for the production and purification of retroviral vectors
03/04/2010US20100055186 Photocrosslinkable oligo(poly (ethylene glycol) fumarate) hydrogels for cell and drug delivery
03/04/2010US20100055184 Hydrogels for vocal cord and soft tissue augmentation and repair
03/04/2010US20100055183 Trimeprazine and ethopropazine derivatives for promoting bone growth